Veradermics, Inc — Director's Dealing 2026

Feb 6, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Veradermics, Inc (MANE)
CIK: 0001827635
Period of Report: 2026-02-03

Reporting Person: Grant-Kels Jane M. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-05	Common Stock	C	2455	—	Acquired	2455	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-05	Series A Convertible Preferred Stock	$	C	2455	Disposed		Common Stock (2455)	Direct
2026-02-03	Stock Option (Right to Buy)	$17	A	51525	Acquired	2036-02-03	Common Stock (51525)	Direct

Footnotes

F1: On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share, on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date.

F2: This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date.